BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7014685)

  • 1. Possible binding of epidermolytic toxin to a subcellular fraction of the epidermis.
    Nishioka K; Katayama I; Sano S
    J Dermatol; 1981 Feb; 8(1):7-12. PubMed ID: 7014685
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermolytic toxin binds to components in the epidermis of a resistant species.
    Smith TP; John DA; Bailey CJ
    Eur J Cell Biol; 1989 Aug; 49(2):341-9. PubMed ID: 2476313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermolytic toxin from Staphylococcus aureus binds to filaggrins.
    Smith TP; Bailey CJ
    FEBS Lett; 1986 Jan; 194(2):309-12. PubMed ID: 2416597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidermolytic toxin of Staphylococcus aureus: its failure to bind to cells and its detection in blister fluids of patients with bullous impetigo.
    Baker DH; Dimond RL; Wuepper KD
    J Invest Dermatol; 1978 Oct; 71(4):274-5. PubMed ID: 701847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible receptor substance for staphylococcal exfoliatin isolated from mice.
    Sakurai S; Kondo I
    Jpn J Med Sci Biol; 1979 Apr; 32(2):85-8. PubMed ID: 541875
    [No Abstract]   [Full Text] [Related]  

  • 6. The epidermolytic toxins are serine proteases.
    Dancer SJ; Garratt R; Saldanha J; Jhoti H; Evans R
    FEBS Lett; 1990 Jul; 268(1):129-32. PubMed ID: 2384148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal exfoliative toxin induces caseinolytic activity.
    Takiuchi I; Kawamura M; Teramoto T; Higuchi D
    J Infect Dis; 1987 Sep; 156(3):508-9. PubMed ID: 2440955
    [No Abstract]   [Full Text] [Related]  

  • 8. ELISA estimation of the binding of epidermolytic toxin to neonatal mouse skin.
    Lockhart BP; Bailey CJ
    Toxicon; 1993 May; 31(5):569-76. PubMed ID: 8332989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The esterolytic activity of epidermolytic toxins.
    Bailey CJ; Redpath MB
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):177-80. PubMed ID: 1599396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reactive serine residue of epidermolytic toxin A.
    Bailey CJ; Smith TP
    Biochem J; 1990 Jul; 269(2):535-7. PubMed ID: 2117445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assays for epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Arbuthnott JP
    Methods Enzymol; 1988; 165():333-8. PubMed ID: 3148097
    [No Abstract]   [Full Text] [Related]  

  • 12. A circular-dichroism study of epidermolytic toxins A and B from Staphylococcus aureus.
    Bailey CJ; Martin SR; Bayley PM
    Biochem J; 1982 Jun; 203(3):775-8. PubMed ID: 7115314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of genes for enterotoxins, toxic shock syndrome toxin 1 and exfoliative toxin among clinical isolates of Staphylococcus pseudintermedius from canine origin.
    Yoon JW; Lee GJ; Lee SY; Park C; Yoo JH; Park HM
    Vet Dermatol; 2010 Oct; 21(5):484-9. PubMed ID: 20500497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Bailey CJ; Arbuthnott JP
    Methods Enzymol; 1988; 165():32-6. PubMed ID: 3231110
    [No Abstract]   [Full Text] [Related]  

  • 15. Nucleotide sequence of the epidermolytic toxin A gene of Staphylococcus aureus.
    O'Toole PW; Foster TJ
    J Bacteriol; 1987 Sep; 169(9):3910-5. PubMed ID: 3040667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of two serotypes of epidermolytic toxin from Staphylococcus aureus.
    Bailey CJ; de Azavedo J; Arbuthnott JP
    Biochim Biophys Acta; 1980 Jul; 624(1):111-20. PubMed ID: 6773585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1.
    Amagai M; Yamaguchi T; Hanakawa Y; Nishifuji K; Sugai M; Stanley JR
    J Invest Dermatol; 2002 May; 118(5):845-50. PubMed ID: 11982763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermolytic toxin. Dermatologic manifestations].
    Agdal N; Jørgensen J; Frentz G; Munkvad JM
    Ugeskr Laeger; 1985 Jun; 147(24):1928-32. PubMed ID: 4024341
    [No Abstract]   [Full Text] [Related]  

  • 19. In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets.
    Mohana R; Venugopal S
    Infect Disord Drug Targets; 2017; 17(2):130-142. PubMed ID: 28034364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial purification and some characteristics of proteinase(s) induced by staphylococcal exfoliative toxin.
    Suzuki K; Teramoto T; Tazawa M; Watanabe H; Takiuchi I
    J Dermatol; 1989 Aug; 16(4):289-95. PubMed ID: 2689489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.